Angara Round Side Ruby Stone Diamond Engagement Ring in White Gold E32oBw5

Angara Round Side Ruby Stone Diamond Engagement Ring in White Gold E32oBw5
Angara Round Side Ruby Stone Diamond Engagement Ring in White Gold
CYBATHLON – moving people and technology
Federal Baseball a Washington Nationals community
Log In or Sign Up
All 319 blogs on

Tanner Roark was better this time around against the Nationals’ NL East rivals, but the Phillies took the series opener in Citizens Bank Park, 4-3.

By Patrick Reddington @federalbaseball
Share Nationals drop third straight, 4-3 Phillies in series opener in Citizens Bank Park...
Vita Fede Super Ultra Mini Titan Ring gc5TN7Dq8
Zales Ladies 50mm Engraved Lightweight Wedding Band in 10K Gold 16 Characters s3g20SZ9o6
Reddit Roberto Coin ROCK amp; DIAMONDS Slim 18K Rose Gold amp; Black Diamond Bangle YDtl3Y0
Flipboard Email

Philadelphia Phillies’ right-hander Aaron Nola dominated the Washington Nationals over 7 2 3 innings tonight in Citizens Bank Park, giving up five hits and one earned run in what ended up a 4-3 win, which extended the starter’s personal unbeaten streak to seven straight starts.

Roark ’s adjustments: Tanner Roark couldn’t get through the fifth last time out against the Phillies during the series in D.C., and he spent the rest of that game watching film to try to identify a mechanical issue that might be behind his struggles.

’s adjustments:

He thought he found a little something.

“Most of the time it’s something very small that you can turn into something way bigger and then it grows from there,” Zales Oval Peridot and LabCreated White Sapphire TriSides Ring in Sterling Silver g1wjgY
said, “... and then you just keep thinking about it and how to change it and it just keeps growing and growing when it’s just something small.”

Tanner Roark's really got some top-notch facial hair going on.

Roark gave up seven hits, four walks, and six earned runs in that outing, after giving up six hits, three walks, and three earned runs in 6 1 3 IP against the Phillies when he faced them back on May 5th.

Try CGM technology that doesn’t require fingerstick calibration.

If you’re a current Dexcom CGM user, you may be eligible for a FreeStyle Libre system reader and one sensor, free of charge*.

* Full eligibility requirements: While supplies last. Offer for one free FreeStyle Libre reader and one FreeStyle Libre sensor is void where prohibited by law. Only current users of Dexcom continuous glucose monitoring devices who are 18 years of age or older are eligible. Beneficiaries of Medicare, Medicaid, and other federal and state healthcare programs, residents of Massachusetts and US territories, and individuals insured by Kaiser Permanente, are not eligible for this offer. The FreeStyle Libre reader and sensor are only available with a valid prescription. The eSample Voucher must be presented with a valid prescription at a participating pharmacy. Participating pharmacies are subject to change without notice to you. The free reader and sensor are provided as a sample and each participant may only redeem one FreeStyle Libre eSample Voucher for one FreeStyle Libre reader and one FreeStyle Libre sensor. Limit one eSample Voucher per person. The eSample Voucher expires 45 days after issuance. Offer is non-transferrable and cannot be combined with any similar offer. The reader and sensor cannot be sold or submitted to any third party payer for reimbursement. Abbott Diabetes Care Inc. reserves the right to modify, rescind, or cancel this program at any time without notice to you.

ADC-06053 Ver 5.0 02/18

Stay Connected

Indications and Important Safety Information

The FreeStyle Libre Flash Glucose Monitoring system is a continuous glucose monitoring (CGM) device indicated for replacing blood glucose testing and detecting trends and tracking patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments in persons (age 18 and older) with diabetes. The system is intended for single patient use and requires a prescription.

CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The FreeStyle Libre system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The FreeStyle Libre system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. Review all product information before use or contact Abbott Toll Free ( 855-632-8658 ) for detailed indications for use and safety information.

For full indications for use and safety information, see more here .

FreeStyle, Libre, and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company. The product images are for illustrative purposes only.

This website and the information contained herein is intended for use by residents of the United States.

ADC-05569 Ver 3.0 05/18

© 2018 Abbott Laboratories. All rights reserved.

Angara Round Pink Sapphire Leverback Dangle Earrings with Diamond vAvNKDQ
Book Now
74-5583 Luhia Street
Kailua-Kona, HI 96740

Cruise the reefs in style on Kona's largest custom dive charter. Dance with mantas. Dive or snorkel with Kona's amazing marine life. Experience the mystery and magic of black water. Learn to dive with our awesome crew. Receive $15 off by booking online and using code gohawaii

Thomas Sabo Thomas Sabo Charm pendant wedding rings white 067305114 ESuJBDlG
28-1710 Honomu Rd.
Honomu, HI 96728

The Newest Big Island Zipline Tour- Cascading nearly 250 ft., one of the World's most spectacular waterfalls passes under your feet as you glide effortlessly through the air.

Learn More
Angara Pear Tanzanite Halo Ring With Diamond Shoulders in 14k White Gold uxQZmnvGN
73-5593A Olowalu Street
Kailua-Kona, HI 96740

Discover Hawaii with one of our renowned Interpretive Guides who will share with you a world of rainforests, waterfalls, cliff-side trails, rare birds, sunrises sunsets atop Maunakea and active volcanoes.

Learn More

Experience the thrill of ziplining on either of our 2 beautiful and unique Maui locations! Enjoy breathtaking views and thrilling zipline adventure in the rugged valleys above Ka’anapali or on the green slopes of Haleakala.

Zales LabCreated White Sapphire and 1/6 CT Tw Diamond Double Row Three Stone Ring in Sterling Silver fcIpdO
Book Now
55-515 Hawi Road
Hawi, HI 96719

Kohala Zipline's Kohala Canopy Adventure features elevated suspension bridges, soaring tree platforms and thrilling ziplines. Whether you are a real zipline enthusiast or a first-time adventure seeker, the Kohala Canopy Adventure will be an unforgettable experience.

Zales 1/10 CT Tw Diamond Infinity Loop Pendant in Sterling Silver and 14K Rose Gold Plate ejnzQNgIFs
Angara Vintage Style Opal Pendant with Diamond Halo a2lALf
307 Lewers Street Suite 401
Honolulu, HI 96815

Join And You Creations on our Nature and You tour! Experienced guides will lead you through the Manoa Valley Rainforest to a breathtaking 150-foot waterfall. Our tour includes transportation from Waikiki and a delicious and healthy lunch. The trail is suitable for all ages and experience levels.


June 26, 2018

BOSTON – 26 June 2018: GE (NYSE: GE) today announced the results of its strategic review. GE will focus on Aviation, Power and Renewable Energy, creating a simpler, stronger, leading high-tech Industrial company. In addition to the pending combination of its Transportation business with Wabtec, GE plans to separate GE Healthcare into a standalone company, pursue an orderly separation from BHGE over the next two to three years, make its corporate structure leaner and substantially reduce debt. GE’s Board of Directors unanimously approved the plans announced today.
John Flannery, chairman and CEO of GE, said, “Today marks an important milestone in GE’s history. We are aggressively driving forward as an aviation, power and renewable energy company—three highly complementary businesses poised for future growth. We will continue to improve our operations and balance sheet as we make GE simpler and stronger.”
Flannery continued, “GE Healthcare and BHGE are excellent examples of GE at its best—anticipating customer needs, breaking barriers through innovation and delivering life-changing products and services. Today’s actions unlock both a pure-play healthcare company and a tier-one oil and gas servicing and equipment player. We are confident that positioning GE Healthcare and BHGE outside of GE’s current structure is best not only for GE and its owners, but also for these businesses, which will strengthen their market-leading positions and enhance their ability to invest for the future, while carrying the spirit of GE forward.”
GE will be a focused high-tech industrial company that will be easier for investors to follow and measure with a significantly improved balance sheet to support its remaining businesses:
GE is making fundamental changes to how it will run the company. The new GE Operating System will result in a smaller corporate headquarters focused primarily on strategy, capital allocation, talent and governance. It will result in better execution, increased speed and is expected to generate at least $500 million in corporate savings by the end of 2020. Under the new GE Operating System, most resources and services traditionally held at the headquarters level will be realigned to the businesses.
GE is targeting an Industrial net debt-to-EBITDA ratio of less than 2.5 times and a long-term A credit rating. GE also plans to reduce Industrial net debt by approximately $25 billion by 2020 and maintain more than $15 billion of cash on the balance sheet.
GE expects to maintain its current quarterly dividend, subject to Board approval, until GE Healthcare is established as an independent entity. At that time, the new GE Healthcare Board of Directors will determine GE Healthcare’s dividend policy, which GE expects to reflect healthcare industry practices. Also at that time, the GE Board expects to adjust the GE dividend with a target dividend policy in line with industrial peers.
Kieran Murphy, president and CEO of GE Healthcare, will continue to lead GE Healthcare as a standalone company, maintaining the GE brand.
“GE Healthcare’s vision is to drive more individualized, precise and effective patient outcomes. As an independent global healthcare business, we will have greater flexibility to pursue future growth opportunities, react quickly to changes in the industry and invest in innovation. We will build on strong customer demand for integrated precision health solutions and great technology with digital and analytics capabilities as we enter our next chapter,” said Mr. Murphy.
Flannery added, “GE Healthcare is an industry leader with financial strength, global scale and cutting-edge technology. Our talented Healthcare team will continue delivering precision health solutions, building on our heritage of technology innovation that delivers patient outcomes.”
GE Healthcare recorded over $19 billion in revenues in 2017 and posted five percent revenue growth and nine percent segment profit growth in the same year. The business provides medical imaging (including contrast agents), monitoring, biomanufacturing and cell therapy technology, leveraging deep digital, artificial intelligence and data analytics capabilities. Its products and services are valued by customers in 140 countries around the world.
GE expects to generate cash from the disposition of approximately 20% of its interest in the Healthcare business and to distribute the remaining 80% to GE shareholders through a tax-free distribution. The structure, sequence and timing of these transactions will be determined and announced at a later date, but are expected to be completed over the next 12 to 18 months. GE Healthcare will conduct business as usual throughout this process, continuing to serve its partners and customers.
GE plans to fully separate its 62.5% interest in BHGE in an orderly manner over the next two to three years. BHGE’s full stream offering brings together equipment, services and digital solutions to help its customers be more productive—a unique and powerful value proposition in a changing market. The separation will provide BHGE with enhanced agility and the ability to focus on leading in the oil and gas industry.
GE continues to work to make GE Capital smaller and more focused on supporting its core industrial businesses. The company intends to materially shrink the balance sheet of GE Capital targeting sales of $25 billion in energy and industrial finance assets by 2020. The company is assuming an approximately $3 billion capital contribution to GE Capital in 2019. In addition, the company is actively exploring options to reduce its insurance exposure.
GE also announced that the Board’s independent directors have completed the previously announced lead director transition, electing Larry Culp, former CEO of Danaher, to succeed Jack Brennan, who is completing his last term on the Board. The change is effective today. Mr. Culp will also chair the Board’s Management Development and Compensation Committee. He joined the GE Board as an independent director earlier this year.
Flannery said, “As lead director, Jack has been an incredibly valuable partner and advisor to GE through economic cycles, changes to our business and our most recent leadership transition. I would like to thank him for his advice and stewardship through a period of significant change for GE. He has been especially helpful over the last year as we have conducted our review of the company and developed our plan to position GE for the future.”
Flannery added, “Larry’s track record on strategy development and execution, capital allocation and talent make him well suited to take on this role. I appreciate his clarity, transparency and business-first philosophy, and I believe his leadership will be invaluable to GE as we enter our next chapter.”
Today’s announcements follow a series of changes GE has made in the past year. With the announced sales of Distributed Power, Industrial Solutions, and Value-Based Care, and pending combination of its Transportation business with Wabtec, GE’s $20 billion divestiture target is substantially complete.
Flannery concluded, “GE’s mission and technology change the lives of billions of people around the world. We will now move forward with purpose to make our company simpler and stronger and accelerate growth across our businesses. I’m confident that today’s actions, in conjunction with other changes we have already made, will produce improved operating results and increased shareholder value going forward. We are focused on executing the strategy and implementing the structure we’ve laid out today to position our businesses for future growth.”
The Company has scheduled an investor conference call to discuss today’s announcement. The call will begin today at 8:30 a.m. Eastern Time , the content of which is not part of this press release. A slide presentation providing summary financial and statistical information that will be discussed on the call will also be posted to the Company’s website and available for real-time viewing at The conference call will be broadcast live via a webcast and can be accessed by visiting the Events and Reports page on the Company’s website at: An archived version of the webcast will be available on the website after the call.
This document contains "forward-looking statements" - that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," “estimate,” “forecast,” "target," “preliminary,” or “range.”
Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about plans to maintain the GE dividend; plans to separate GE Healthcare as a standalone company, including the timing and structure for that separation, the characteristics of the business to be separated and the expected benefits to GE; plans to divest our equity ownership position in Baker Hughes, a GE Company (BHGE) and the expected benefits to GE; debt repayment plans; the benefits of the new GE Operating System; divestiture proceeds expectations; GE and GE Capital liquidity; revenues; future corporate performance; and leverage targets.
For us, particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include:
These or other uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
In this document, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP). Certain of these data are considered “non-GAAP financial measures” under the U.S. Securities and Exchange Commission rules. These non-GAAP financial measures supplement our GAAP disclosures and should not be considered an alternative to the GAAP measure. The non-GAAP financial measures we use in this document include Industrial net debt and the ratio of Industrial net debt to EBITDA. We cannot provide an equivalent GAAP guidance range for our Industrial net debt to EBITDA targets, which are calculated based on rating agency methodologies, without unreasonable effort. Industrial net debt reflects the total of gross debt, after-tax pension contributions, adjustments for operating lease obligations, and adjustments for 50% of preferred stock, less 75% of GE’s cash balance. There is significant uncertainty on the timing and amount of events that could give rise to items included in the determination of this metric, including the timing of pension funding, proceeds from dispositions, and the impact of interest rates on our pension assets and liabilities. EBITDA excludes Oil Gas EBITDA, but it includes the BHGE dividend, and it also excludes other income, non-operating benefits costs, and adjustments for operating lease income or cost. There is significant uncertainty on the timing and amount of events that could give rise to items included in the determination of this metric, including the timing and magnitude of restructuring activities and the timing of dispositions.
GE (NYSE:GE) drives the world forward by tackling its biggest challenges: Energy, health, transportation—the essentials of modern life. By combining world-class engineering with software and analytics, GE helps the world work more efficiently, reliably, and safely. For more than 125 years, GE has invented the future of industry, and today it leads new paradigms in additive manufacturing, materials science, and data analytics. GE people are global, diverse and dedicated, operating with the highest integrity and passion to fulfill GE’s mission and deliver for our customers.
GE Investor Contact:
Matt Cribbins, 617.443.3400
GE Media Contact:
Jennifer Erickson, 646.682.5620


Media Resources

GE Corporate

Back to top
International Centre for Trade and Sustainable Development
International Environment House 2 Chemin de Balexert 7-9 1219 Châtelaine Geneva Switzerland
Phone: +41 22 917 84 92 Fax: +41 22 917 80 93 Email: Angara Round Citrine Halo Ring with Diamond Accents in 14K White Gold yp9uLYW